Samsung Biologics
Samsung BioLogics faces FDA scrutiny over data integrity and quality issues at Korean plant
Anika Sharma
The FDA recently issued manufacturing alerts, targeting high-flying companies Samsung Biologics and Nectar Lifesciences. For Samsung Biologics, a notable player ...
Samsung Biologics expands antibody production deal with Bristol Myers Squibb for $242 million
Anika Sharma
Samsung Biologics, a leading biopharmaceutical contract manufacturing organization, has strengthened its partnership with Bristol Myers Squibb (BMS) by securing a ...
Samsung Biologics Secures $411 Million Long-Term Deal with Pfizer for Biosimilar Production
SG Tylor
South Korea’s Samsung Biologics has recently entered into another significant manufacturing agreement, this time with Pfizer, worth $411 million. The ...
